However, because BPC-157 is no longer on the FDA's 503A bulk drug substance list as of 2023, no legitimate 503A pharmacy can legally compound it, and any source claiming 503A compliance for BPC-157 is making a legally incoherent claim worth scrutinizing carefully
This approach may prevent copper accumulation while maintaining therapeutic benefits
Ingredients Water, Glycerin, PEG-8, Niacinamide, Butylene Glycol, Methylpropanediol, 1-2-Hexanediol, Betaine, Glycereth-26, Bis-PEG-18 Methyl Ether Dimethyl Silane, Polyglyceryl-10 Laurate, Bifida Ferment Lysate, Methyl Gluceth-20, Panthenol, Squalane, Glucosylrutin, Hydrogenated Lecithin, Carbomer, Caprylic/Capric Triglyceride, Tromethamine, Xanthan Gum, Propanediol, Flavor, Ethylhexylglycerin, Glutathione (500 ppm), Adenosine, Ceramide NP, Sodium Phytate, Benzyl Glycol, Hydrolyzed Glycosaminoglycans, Sodium Hyaluronate, Dextrin, Theobroma Cacao (Cocoa) Extract, Beta-Glucan, Cyanocobalamin, Sodium Hyaluronate Crosspolymer, Tocopherol, Hydrolyzed Hyaluronic Acid, Hydroxypropyltrimonium Hyaluronate, Soluble Collagen, Hyaluronic Acid, Sodium Acetylated Hyaluronate, Sodium Stearoyl Glutamate The manufacturer is responsible for the products ingredients
Despite the lack of human study, it should be taken into account that BPC 157 is a peptide derived from human gastric juices
Meanwhile, oxidative stress from excess copper depletes glutathione, catalase, and superoxide dismutase the same antioxidants that protect mitochondria and neurons
In vitro, ChaC1 induces cell death in KIRC cell lines, signifying its potential as an effective marker for poor prognosis in KIRC (70)
